Search Results - "KANBE, Yoshitake"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Thiochroman Derivative CH4986399, A New Nonsteroidal Estrogen Receptor Down-regulator, Is Effective in Breast Cancer Models by YONEYA, Takaaki, TANIGUCHI, Kenji, NAKAMURA, Ryo, TSUNENARI, Toshiaki, OHIZUMI, Iwao, KANBE, Yoshitake, MORIKAWA, Kazumi, KAIHO, Shin-Ichi, YAMADA-OKABE, Hisafumi

    Published in Anticancer research (01-03-2010)
    “…Tamoxifen, a selective estrogen receptor modulator, and fulvestrant, a selective estrogen receptor down-regulator (SERD), are now available for estrogen…”
    Get full text
    Journal Article
  3. 3

    Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levels by YONEYA, Takaaki, TSUNENARI, Toshiaki, TANIGUCHI, Kenji, KANBE, Yoshitake, MORIKAWA, Kazumi, YAMADA-OKABE, Hisafumi, YEON-HOLEE, LEE, Mee-Hyun, KWON, Lae-Sung

    Published in Oncology reports (01-03-2009)
    “…We compared the antitumor efficacy and estrogen receptor (ER) degradation of CH4893237, a new orally active selective ER downregulator, with fulvestrant and…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Newly discovered orally active pure antiestrogens by Kanbe, Yoshitake, Kim, Myung-Hwa, Nishimoto, Masahiro, Ohtake, Yoshihito, Yoneya, Takaaki, Ohizumi, Iwao, Tsunenari, Toshiaki, Taniguchi, Kenji, Kaiho, Shin-ichi, Nabuchi, Yoshiaki, Araya, Hiroshi, Kawata, Setsu, Morikawa, Kazumi, Jo, Jae-Chon, Kwon, Hee-An, Lim, Hyun-Suk, Kim, Hak-Yeop

    Published in Bioorganic & medicinal chemistry letters (15-09-2006)
    “…Steroid derivatives bearing the carboxy moiety in the long side chain at the 7-α position exhibited remarkable antiestrogen activities when administered…”
    Get full text
    Journal Article
  6. 6

    Identification of a novel, orally bioavailable estrogen receptor downregulator by Yoneya, Takaaki, Taniguchi, Kenji, Tsunenari, Toshiaki, Saito, Hidemi, Kanbe, Yoshitake, Morikawa, Kazumi, Yamada-Okabe, Hisafumi

    Published in Anti-cancer drugs (01-08-2005)
    “…Tamoxifen has been widely used for the treatment of estrogen receptor (ER)-positive breast cancer, but its partial agonist activity is considered to limit the…”
    Get full text
    Journal Article
  7. 7